Navigation

Costing tools

Costing tools are normally provided for each technology appraisal, quality standard, medical technology, diagnostic technology, clinical guideline and public health guidance. Costing tools are not provided for interventional procedures.

Types of costing tool

NICE provides five types of costing tool:

  • national cost reports summarise the national estimate cost and discuss the assumptions made when estimating the financial impact of implementing the guidance. For technology appraisals, the report is incorporated into the costing template.
  • costing templates support estimating the local cost of implementing guidance. and public health guidelines. These templates allow individual NHS organisations and local health economies to quickly assess the impact guidance will have on local budgets. A video tutorial explaining how to use the costing templates is available in Windows Media Player and Quick Time format.
  • business case. It presents the financial costs and benefits of implementing guidance.
  • cost impact and commissioning assessment for NICE quality standards
  • costing statements are used when cost impact is considered to be minimal to explain why the cost impact is not considered to be significant.
  • NICE support for commissioners and others using the quality standard

All guidance published since January 2005 has costing tools. Costing tools currently available are listed below.

Further information on the methodology for developing costing tools.

Results 21-40 of 515

Ref Title
CG42 Dementia: costing template
CG42 Dementia: supplementary costing report and template
CG44 Heavy menstrual bleeding: costing report
CG44 Heavy menstrual bleeding: costing template
CG45 Antenatal and postnatal mental health: costing template
CG45 Antenatal and postnatal mental health: costing report
IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures: Costing report
PH2 Four commonly used methods to increase physical activity: costing report
PH2 Four commonly used methods to increase physical activity: costing template
PH1 Brief interventions and referral for smoking cessation: costing template
PH1 Brief interventions and referral for smoking cessation: costing report
PH3 Prevention of sexually transmitted infections and under 18 conceptions: costing template
PH3 Prevention of sexually transmitted infections and under 18 conceptions: costing report
PH4 Interventions to reduce substance misuse among vulnerable young people: implementation and costing statement
TA95 Arrhythmia - implantable cardioverter defibrillators (ICDs) (review): analysis of cost impact
TA99 Renal transplantation - immunosuppressive regimens for children and adolescents: costing statement
TA103 Psoriasis - efalizumab and etanercept: Costing template and report
TA107 Breast cancer (early) - trastuzumab: costing template and report
TA105 Colorectal cancer - laparoscopic surgery: costing template and report
TA106 Hepatitis C - peginterferon alfa and ribavirin: costing template and report

This page was last updated: 31 August 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.